Literature DB >> 27663838

Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria.

J M Ageitos1, A Sánchez-Pérez2, P Calo-Mata3, T G Villa4.   

Abstract

Antimicrobial peptides (AMPs) are short peptidic molecules produced by most living creatures. They help unicellular organisms to successfully compete for nutrients with other organisms sharing their biological niche, while AMPs form part of the immune system of multicellular creatures. Thus, these molecules represent biological weapons that have evolved over millions of years as a result of an escalating arms race for survival among living organisms. All AMPs share common features, such as a small size, with cationic and hydrophobic sequences within a linear or cyclic structure. AMPs can inhibit or kill bacteria at micromolar concentrations, often by non-specific mechanisms; hence the appearance of resistance to these antimicrobials is rare. Moreover, AMPs can kill antibiotic-resistant bacteria, including insidious microbes such as Acinetobacter baumannii and the methicillin-resistant Staphylococcus aureus. This review gives a detailed insight into a selection of the most prominent and interesting AMPs with antibacterial activity. In the near future AMPs, due to their properties and despite their ancient origin, should represent a novel alternative to antibiotics in the struggle to control pathogenic microorganisms and maintain the current human life expectancy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptides; Cathelicidins; Defensins; Gram negative; Gram positive

Mesh:

Substances:

Year:  2016        PMID: 27663838     DOI: 10.1016/j.bcp.2016.09.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  101 in total

1.  Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues.

Authors:  Takashi Misawa; Chihiro Goto; Norihito Shibata; Motoharu Hirano; Yutaka Kikuchi; Mikihiko Naito; Yosuke Demizu
Journal:  Medchemcomm       Date:  2019-04-04       Impact factor: 3.597

Review 2.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

Review 3.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

4.  Self-Association of Antimicrobial Peptides: A Molecular Dynamics Simulation Study on Bombinin.

Authors:  Peicho Petkov; Elena Lilkova; Nevena Ilieva; Leandar Litov
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

Review 5.  Bio-instructive materials for musculoskeletal regeneration.

Authors:  Tomas Gonzalez-Fernandez; Pawel Sikorski; J Kent Leach
Journal:  Acta Biomater       Date:  2019-07-11       Impact factor: 8.947

6.  Characterization of an L-α,β-diaminopropionic acid polymer with comb-like structure isolated from a poly(ε-L-lysine)-producing Streptomyces sp.

Authors:  Munenori Takehara; Masayuki Saimura; Haruka Inaba; Yoshinao Kato; Shogo Muro; Tatsuki Matsunaga; Kazuya Yamanaka
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-12       Impact factor: 4.813

7.  Unveiling the active isomer of cycloalanopine, a cyclic opine from Lactobacillus rhamnosus LS8, through synthesis and analog production.

Authors:  Isaac Antwi; Sorina Chiorean; Marco J van Belkum; John C Vederas
Journal:  RSC Med Chem       Date:  2020-04-06

Review 8.  Development of coinage metal nanoclusters as antimicrobials to combat bacterial infections.

Authors:  Dan Li; Beena Kumari; Jessa Marie Makabenta; Bailong Tao; Kun Qian; Xifan Mei; Vincent M Rotello
Journal:  J Mater Chem B       Date:  2020-10-28       Impact factor: 6.331

9.  Constitutive expression of antimicrobial peptide PR-39 in transgenic mice significantly enhances resistance to bacterial infection and promotes growth.

Authors:  Fang Zeng; Rui Dong; Chengcheng Zhao; Dewu Liu; Enqin Zheng; Changxu Song; Zhenfang Wu; Zicong Li
Journal:  Transgenic Res       Date:  2018-07-12       Impact factor: 2.788

10.  ABC Transporter DerAB of Lactobacillus casei Mediates Resistance against Insect-Derived Defensins.

Authors:  Ainhoa Revilla-Guarinos; Qian Zhang; Christoph Loderer; Cristina Alcántara; Ariane Müller; Mohammad Rahnamaeian; Andreas Vilcinskas; Susanne Gebhard; Manuel Zúñiga; Thorsten Mascher
Journal:  Appl Environ Microbiol       Date:  2020-07-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.